Global Heart Defect Closure Devices Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Heart Defect Closure Devices market size was valued at US$ 390 million in 2024 and is forecast to a readjusted size of USD 539 million by 2031 with a CAGR of 4.8% during review period.

Heart defect closure devices are permanent implants designed to close defects between chambers of the heart or a patent ductus arteriosus. These are self-expandable, self-centering umbrella-like devices. The design and shape of the devices vary, as does their exact mode of deployment. They are implanted in the defect in a cardiac catheterization laboratory, through catheters inserted into either a vein or an artery (transcatheter or percutaneous approach). There are several types of defects, which include atrial septal defect (ASD), persistent patent ductus arteriosus (PDA), ventricular septal defect (VSD), patent foramen ovale (PFO), and left atrial appendage (LAA). Most of these defects are congenital, but can occur after a myocardial infarction or can be the result of a surgical repair of other congenital heart defects.

Global Heart Defect Closure Devices key players include St. Jude Medical, Starway, LifeTech, etc. Global top three manufacturers hold a share about 85%.

United States is the largest market, with a share about 70%, followed by Europe and China, both have a share over 25 percent.

In terms of product, ASD Closure Devices is the largest segment, with a share about 40%.

This report is a detailed and comprehensive analysis for global Heart Defect Closure Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Heart Defect Closure Devices market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2020-2031

Global Heart Defect Closure Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2020-2031

Global Heart Defect Closure Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (USD/Unit), 2020-2031

Global Heart Defect Closure Devices market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (USD/Unit), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Heart Defect Closure Devices

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Heart Defect Closure Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, Boston Scientific, LifeTech, Lepu Medical, Occlutech, W. L. Gore and Associates, Starway, Coherex Medical, Cardia, MicroPort, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Heart Defect Closure Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
ASD Closure Devices
VSD Closure Devices
PDA Closure Devices
PFO Closure Devices
LAA Closure Devices

Market segment by Application
Hospitals
Clinics

Major players covered
Abbott
Boston Scientific
LifeTech
Lepu Medical
Occlutech
W. L. Gore and Associates
Starway
Coherex Medical
Cardia
MicroPort

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Heart Defect Closure Devices product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Heart Defect Closure Devices, with price, sales quantity, revenue, and global market share of Heart Defect Closure Devices from 2020 to 2025.

Chapter 3, the Heart Defect Closure Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Heart Defect Closure Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Heart Defect Closure Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Heart Defect Closure Devices.

Chapter 14 and 15, to describe Heart Defect Closure Devices sales channel, distributors, customers, research findings and conclusion.